Funded startups/Theradaptive, Inc.

Theradaptive, Inc.

SEC filing

Biotechnology · Frederick, MD

Form D on EDGAR

Amount raised$36.2Msold at filing

Total offering$77.9M$41.8M still open

Investors in the raise65count reported to the SEC

FiledAug 4, 2026first sale Jul 21, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Jeffrey A. DunnDirector

David A. HarringtonDirector

David StewartExecutive Officer, Director

Patrick A. ZhangDirector

Luis AlvarezExecutive Officer, Director

Ted A. MeyersDirector

George A. ShanineDirector

Executive officers, directors and promoters as listed on the Form D.